{"gene":"CHRNA4","run_date":"2026-06-09T22:57:18","timeline":{"discoveries":[{"year":1997,"finding":"An insertion of three nucleotides (GCT) at position 776 in the M2 domain of CHRNA4 does not prevent receptor function but increases apparent affinity for ACh and significantly lowers calcium permeability of the reconstituted receptor, corresponding to a loss-of-function at the cellular level.","method":"Receptor reconstitution and electrophysiological characterization in heterologous expression system","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with functional electrophysiology, single lab but two distinct functional parameters measured (ACh affinity and calcium permeability)","pmids":["9175743"],"is_preprint":false},{"year":1999,"finding":"A C755T missense mutation in exon 5 of CHRNA4 replaces Ser252 (a conserved residue in the M2 channel-lining domain) with leucine, causing ADNFLE; the serine at this position is considered important for channel function.","method":"SSCP, direct sequencing, segregation analysis","journal":"Neurology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — genetic/sequencing identification with segregation, no direct functional reconstitution in this paper; replicated across multiple ADNFLE families","pmids":["10563623"],"is_preprint":false},{"year":2003,"finding":"A novel CHRNA4 mutation (T265I) at the extracellular end of the second transmembrane domain increases ACh sensitivity of mutated α4β2 receptors as demonstrated by expression in Xenopus oocytes.","method":"Expression in Xenopus oocytes, electrophysiological characterization","journal":"Epilepsia","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct functional reconstitution in Xenopus oocyte system with electrophysiology, single lab","pmids":["12823585"],"is_preprint":false},{"year":2003,"finding":"The Chrna4 A529T polymorphism in the second intracellular loop of the α4 subunit alters the ratio of high- to low-affinity α4β2 nAChR populations: the T529 variant exhibits a higher EC50 for the high-affinity population and a greater proportion of high-affinity receptors (64%) compared with A529 (41%), and shows reduced sensitivity to DHβE blockade.","method":"Heterologous expression of mouse α4 variants with β2 subunit, electrophysiology","journal":"Neuropharmacology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with functional electrophysiology comparing two variant forms, single lab with multiple functional endpoints","pmids":["12871652"],"is_preprint":false},{"year":2003,"finding":"The Chrna4 A529 polymorphism (versus T529) in mouse strains enables ethanol (10–100 mM) to enhance maximal nicotine-stimulated 86Rb+ efflux from thalamic synaptosomes; one copy of the A allele is sufficient for this enhancement, and the effect requires the β2 subunit.","method":"86Rb+ efflux assay in thalamic synaptosomes from inbred mouse strains and F2 hybrids","journal":"Alcoholism, clinical and experimental research","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro functional assay replicated across six inbred strains and F2 intercross, multiple genetic backgrounds tested","pmids":["12766617"],"is_preprint":false},{"year":2008,"finding":"Transgenic rats expressing the CHRNA4 S284L mutation show attenuation of synaptic and extrasynaptic GABAergic transmission and abnormal glutamate release during slow-wave sleep, establishing that this gain-of-function mutation disrupts inhibitory neurotransmission as a mechanism for NFLE seizures.","method":"Transgenic rat model (knock-in S284L), electrophysiological recordings of synaptic transmission, behavioral seizure phenotyping","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean transgenic knock-in animal model with defined cellular electrophysiology phenotype (GABAergic and glutamatergic transmission), multiple readouts","pmids":["19020039"],"is_preprint":false},{"year":2010,"finding":"Chrna4 A529 knock-in mice exhibit greater sensitivity to nicotine-induced hypothermia, reduced oral nicotine consumption, no conditioned place preference to nicotine, and altered α4β2* nAChR function in midbrain (greater maximal Rb+ efflux and higher proportion of high-sensitivity receptors), demonstrating that the T529A polymorphism causally influences nicotine sensitivity through midbrain α4β2* nAChRs.","method":"Knock-in mouse model, behavioral pharmacology, acetylcholine-stimulated Rb+ efflux in midbrain","journal":"Pharmacogenetics and genomics","confidence":"High","confidence_rationale":"Tier 2 / Strong — knock-in model with multiple orthogonal behavioral and biochemical endpoints, definitively assigns causal role to polymorphism","pmids":["20061993"],"is_preprint":false},{"year":2014,"finding":"Three rare CHRNA4 variants (α4R336C, α4P451L, α4R487Q) alter α4β2 nAChR expression, subcellular distribution, sensitivity to nicotine-induced receptor upregulation, intracellular interactome composition (by LC-MS/MS), and electrophysiological parameters of agonist activation in Xenopus oocytes, indicating that single amino acid substitutions in CHRNA4 affect receptor assembly and pharmacology.","method":"[3H]epibatidine binding, LC-MS/MS proteomics of immunopurified receptors, voltage-clamp electrophysiology in Xenopus oocytes, subcellular fractionation in HEK293 cells","journal":"The Journal of pharmacology and experimental therapeutics","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple orthogonal methods (binding, proteomics, electrophysiology, fractionation) in a single study characterizing three variants","pmids":["24385388"],"is_preprint":false},{"year":2023,"finding":"Hepatocyte-expressed CHRNA4 mediates MASH progression by acting as an ionotropic receptor: acetylcholine (from immune cells) or nicotine activates hepatocyte CHRNA4, inducing calcium influx and activation of inflammatory signaling, leading to cytokine production and liver inflammation. Genetic and pharmacological inhibition of CHRNA4 protected mice from diet-induced MASH.","method":"Conditional knockout mice, pharmacological inhibition, calcium imaging, inflammatory cytokine measurements, dietary MASH model","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean genetic (KO) and pharmacological loss-of-function with defined cellular mechanism (calcium influx, inflammatory signaling) and disease phenotype rescue","pmids":["38056431"],"is_preprint":false},{"year":2023,"finding":"METTL3-mediated m6A modification is enriched on Chrna4 mRNA in hippocampal neurons following BPA exposure, leading to decreased Chrna4 expression; inhibition or knockdown of METTL3 restores Chrna4 expression and rescues BPA-induced spatial memory deficits and abnormal synaptic transmission.","method":"m6A sequencing/MeRIP, METTL3 inhibitor and shRNA knockdown in neurons and rats, synaptic transmission recordings, behavioral memory testing","journal":"Environmental research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple methods (m6A profiling, genetic KD, pharmacological inhibition, behavioral rescue) in single lab; m6A site on Chrna4 mRNA identified but direct reader/eraser not fully characterized","pmids":["37495067"],"is_preprint":false},{"year":1996,"finding":"The human CHRNA4 gene consists of six exons distributed over approximately 17 kb of genomic DNA, providing the structural basis for mutation screening of the complete coding region.","method":"Genomic sequencing, Southern blot analysis, PCR amplification","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct genomic characterization establishing gene structure; foundational for all subsequent mutation studies","pmids":["8833159"],"is_preprint":false}],"current_model":"CHRNA4 encodes the α4 subunit of the neuronal nicotinic acetylcholine receptor (nAChR); it assembles with the β2 subunit to form high-affinity α4β2 ion channels that conduct calcium and are gated by acetylcholine/nicotine, with disease-causing mutations in the M2 channel-lining domain increasing ACh sensitivity or reducing calcium permeability, a polymorphism in the second intracellular loop (A/T529) controlling the ratio of high- to low-affinity receptor populations and their ethanol modulation, rare coding variants altering receptor assembly/expression/pharmacology, METTL3-mediated m6A modification on CHRNA4 mRNA suppressing its expression and impairing synaptic transmission, and hepatocyte CHRNA4 specifically mediating acetylcholine/nicotine-induced calcium influx and inflammatory signaling to drive metabolic liver disease."},"narrative":{"mechanistic_narrative":"CHRNA4 encodes the α4 subunit of a neuronal nicotinic acetylcholine receptor that assembles with the β2 subunit to form an acetylcholine/nicotine-gated, calcium-conducting ion channel [PMID:12766617, PMID:20061993]. The M2 channel-lining domain is the critical functional determinant: mutations there alter receptor behavior, with an M2 GCT insertion increasing apparent ACh affinity while reducing calcium permeability [PMID:9175743], and the S252L and T265I substitutions in the same region increasing ACh sensitivity and causing autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE/NFLE) [PMID:10563623, PMID:12823585]. The gain-of-function S284L mutation expressed in transgenic rats attenuates GABAergic transmission and produces abnormal glutamate release during slow-wave sleep, establishing disrupted inhibitory neurotransmission as the seizure mechanism [PMID:19020039]. A polymorphism in the second intracellular loop (A529/T529) shifts the ratio of high- to low-affinity α4β2 receptor populations and their pharmacology in a β2-dependent manner [PMID:12871652], and in knock-in mice this variant causally modulates nicotine sensitivity, consumption, and reward through midbrain α4β2* receptors and gates ethanol enhancement of nicotine-stimulated cation efflux [PMID:12766617, PMID:20061993]. Rare coding variants (R336C, P451L, R487Q) further perturb receptor expression, subcellular distribution, nicotine-induced upregulation, intracellular interactome, and agonist pharmacology [PMID:24385388]. Beyond the nervous system, hepatocyte CHRNA4 acts as an ionotropic receptor whose activation by immune-cell-derived acetylcholine or nicotine drives calcium influx and inflammatory signaling to promote metabolic dysfunction-associated steatohepatitis (MASH) [PMID:38056431]. CHRNA4 expression is also subject to METTL3-mediated m6A modification of its mRNA, which suppresses its expression and impairs synaptic transmission [PMID:37495067].","teleology":[{"year":1996,"claim":"Defining the genomic organization of CHRNA4 was the prerequisite for systematic mutation screening, answering how the coding region is structured.","evidence":"genomic sequencing, Southern blot, and PCR mapping of the human gene","pmids":["8833159"],"confidence":"Medium","gaps":["Provides no functional or regulatory information","Does not address protein assembly or channel properties"]},{"year":1997,"claim":"Reconstitution of an M2-domain insertion mutant established that CHRNA4 mutations can dissociate gating from permeation, increasing ACh affinity while lowering calcium permeability.","evidence":"receptor reconstitution and electrophysiology in a heterologous expression system","pmids":["9175743"],"confidence":"High","gaps":["Single lab, single mutant","Does not establish in vivo or disease consequence"]},{"year":1999,"claim":"Genetic identification of the S252L M2 mutation linked CHRNA4 channel-lining residues to ADNFLE, implicating M2 integrity in disease.","evidence":"SSCP, direct sequencing, and segregation analysis in ADNFLE families","pmids":["10563623"],"confidence":"Medium","gaps":["No direct functional reconstitution in this study","Mechanism connecting mutation to seizures not resolved here"]},{"year":2003,"claim":"Functional reconstitution of the T265I mutation showed that disease-associated M2 substitutions confer increased ACh sensitivity, defining a gain-of-function pharmacology.","evidence":"expression of mutant α4β2 in Xenopus oocytes with electrophysiology","pmids":["12823585"],"confidence":"High","gaps":["Single lab","Link from altered sensitivity to circuit dysfunction not tested"]},{"year":2003,"claim":"Characterization of the A529T intracellular-loop polymorphism established that non-M2 variants tune the proportion and affinity of receptor populations and their antagonist sensitivity.","evidence":"heterologous expression of α4 variants with β2 and electrophysiology; 86Rb+ efflux in mouse thalamic synaptosomes showing β2-dependent ethanol enhancement","pmids":["12871652","12766617"],"confidence":"High","gaps":["In vitro and synaptosomal assays only","Behavioral relevance not yet established at this stage"]},{"year":2008,"claim":"A transgenic S284L rat connected a CHRNA4 gain-of-function mutation to attenuated GABAergic transmission and abnormal glutamate release during slow-wave sleep, providing a circuit-level mechanism for NFLE seizures.","evidence":"knock-in transgenic rat with synaptic electrophysiology and seizure phenotyping","pmids":["19020039"],"confidence":"High","gaps":["Single mutation model","Does not address how altered channel kinetics map to network changes"]},{"year":2010,"claim":"A529 knock-in mice assigned a causal role for the polymorphism in nicotine sensitivity, consumption, and reward via midbrain α4β2* receptors.","evidence":"knock-in mouse, behavioral pharmacology, and ACh-stimulated Rb+ efflux in midbrain","pmids":["20061993"],"confidence":"High","gaps":["Mouse variant; human translation not directly tested","Circuit specificity beyond midbrain not resolved"]},{"year":2014,"claim":"Multi-modal characterization of three rare coding variants showed that single substitutions reshape receptor expression, trafficking, upregulation, intracellular interactome, and pharmacology.","evidence":"epibatidine binding, LC-MS/MS of immunopurified receptors, oocyte electrophysiology, HEK293 subcellular fractionation","pmids":["24385388"],"confidence":"High","gaps":["Interactome partners not individually validated","In vivo phenotype of these variants not tested"]},{"year":2023,"claim":"Hepatocyte CHRNA4 was established as an ionotropic driver of liver disease, where acetylcholine/nicotine triggers calcium influx and inflammatory signaling to promote MASH.","evidence":"conditional knockout and pharmacological inhibition in a dietary MASH model with calcium imaging and cytokine measurement","pmids":["38056431"],"confidence":"High","gaps":["Subunit composition of the hepatic receptor not defined","Downstream inflammatory signaling steps only partially mapped"]},{"year":2023,"claim":"m6A profiling identified CHRNA4 mRNA as a METTL3 target whose methylation suppresses expression and impairs synaptic transmission after BPA exposure.","evidence":"MeRIP/m6A sequencing, METTL3 inhibitor and shRNA knockdown, synaptic recordings, and behavioral memory testing in neurons and rats","pmids":["37495067"],"confidence":"Medium","gaps":["m6A reader/eraser controlling CHRNA4 not identified","Direct causality from a specific methylation site not fully resolved"]},{"year":null,"claim":"The subunit composition and structural basis of non-neuronal (hepatocyte) CHRNA4 receptors and how the same channel mediates both seizure-related neurotransmission and peripheral inflammatory signaling remain unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural model of mutant or hepatic receptors in the corpus","Tissue-specific assembly partners beyond β2 not defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,2,3,4,6,8]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,2,4,6,8]},{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,8]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[7,8]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[5,6,9]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[8]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[1,5,8]}],"complexes":["α4β2 nicotinic acetylcholine receptor"],"partners":["CHRNB2","METTL3"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P43681","full_name":"Neuronal acetylcholine receptor subunit alpha-4","aliases":[],"length_aa":627,"mass_kda":70.0,"function":"Component of neuronal acetylcholine receptors (nAChRs) that function as pentameric, ligand-gated cation channels with high calcium permeability among other activities. nAChRs are excitatory neurotrasnmitter receptors formed by a collection of nAChR subunits known to mediate synaptic transmission in the nervous system and the neuromuscular junction. Each nAchR subunit confers differential attributes to channel properties, including activation, deactivation and desensitization kinetics, pH sensitivity, cation permeability, and binding to allosteric modulators (PubMed:22361591, PubMed:27698419, PubMed:29720657, PubMed:38454578). CHRNA4 forms heteropentameric neuronal acetylcholine receptors with CHRNB2 and CHRNB4, as well as CHRNA5 and CHRNB3 as accesory subunits. Is the most abundant nAChR subtype expressed in the central nervous system (PubMed:16835356, PubMed:22361591, PubMed:27698419, PubMed:29720657, PubMed:38454578). Found in two major stoichiometric forms,(CHRNA4)3:(CHRNB2)2 and (CHRNA4)2:(CHRNB2)3, the two stoichiometric forms differ in their unitary conductance, calcium permeability, ACh sensitivity and potentiation by divalent cation (PubMed:27698419, PubMed:29720657, PubMed:38454578). Involved in the modulation of calcium-dependent signaling pathways, influences the release of neurotransmitters, including dopamine, glutamate and GABA (By similarity)","subcellular_location":"Synaptic cell membrane; Cell membrane","url":"https://www.uniprot.org/uniprotkb/P43681/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CHRNA4","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CHRNA4","total_profiled":1310},"omim":[{"mim_id":"615005","title":"EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5","url":"https://www.omim.org/entry/615005"},{"mim_id":"614168","title":"PHOSPHOENOLPYRUVATE CARBOXYKINASE 1, SOLUBLE; PCK1","url":"https://www.omim.org/entry/614168"},{"mim_id":"610509","title":"RIC3 ACETYLCHOLINE RECEPTOR CHAPERONE; RIC3","url":"https://www.omim.org/entry/610509"},{"mim_id":"607834","title":"ANXIETY","url":"https://www.omim.org/entry/607834"},{"mim_id":"606888","title":"CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 6; CHRNA6","url":"https://www.omim.org/entry/606888"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"liver","ntpm":82.6}],"url":"https://www.proteinatlas.org/search/CHRNA4"},"hgnc":{"alias_symbol":["BFNC"],"prev_symbol":["EBN","EBN1"]},"alphafold":{"accession":"P43681","domains":[{"cath_id":"2.70.170.10","chopping":"34-242","consensus_level":"high","plddt":94.0011,"start":34,"end":242},{"cath_id":"1.20.58","chopping":"248-363_584-626","consensus_level":"high","plddt":86.631,"start":248,"end":626}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P43681","model_url":"https://alphafold.ebi.ac.uk/files/AF-P43681-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P43681-F1-predicted_aligned_error_v6.png","plddt_mean":71.94},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CHRNA4","jax_strain_url":"https://www.jax.org/strain/search?query=CHRNA4"},"sequence":{"accession":"P43681","fasta_url":"https://rest.uniprot.org/uniprotkb/P43681.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P43681/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P43681"}},"corpus_meta":[{"pmid":"9175743","id":"PMC_9175743","title":"An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy.","date":"1997","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9175743","citation_count":300,"is_preprint":false},{"pmid":"10563623","id":"PMC_10563623","title":"A novel mutation of CHRNA4 responsible for autosomal dominant nocturnal frontal lobe epilepsy.","date":"1999","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/10563623","citation_count":169,"is_preprint":false},{"pmid":"15790597","id":"PMC_15790597","title":"Ethnic- and gender-specific association of the nicotinic acetylcholine receptor alpha4 subunit gene (CHRNA4) with nicotine dependence.","date":"2005","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15790597","citation_count":158,"is_preprint":false},{"pmid":"17768273","id":"PMC_17768273","title":"CHRNA4 and tobacco dependence: from gene regulation to treatment outcome.","date":"2007","source":"Archives of general psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/17768273","citation_count":93,"is_preprint":false},{"pmid":"26440539","id":"PMC_26440539","title":"Genome-wide meta-analysis reveals common splice site acceptor variant in CHRNA4 associated with nicotine dependence.","date":"2015","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/26440539","citation_count":73,"is_preprint":false},{"pmid":"10448807","id":"PMC_10448807","title":"Autosomal dominant nocturnal frontal lobe epilepsy in a Spanish family with a Ser252Phe mutation in the CHRNA4 gene.","date":"1999","source":"Archives of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/10448807","citation_count":72,"is_preprint":false},{"pmid":"16869227","id":"PMC_16869227","title":"Interactive effects of APOE and CHRNA4 on attention and white matter volume in healthy middle-aged and older adults.","date":"2006","source":"Cognitive, affective & behavioral neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/16869227","citation_count":72,"is_preprint":false},{"pmid":"10802757","id":"PMC_10802757","title":"Independent occurrence of the CHRNA4 Ser248Phe mutation in a Norwegian family with nocturnal frontal lobe epilepsy.","date":"2000","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/10802757","citation_count":68,"is_preprint":false},{"pmid":"12823585","id":"PMC_12823585","title":"A new Chrna4 mutation with low penetrance in nocturnal frontal lobe epilepsy.","date":"2003","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/12823585","citation_count":66,"is_preprint":false},{"pmid":"17613539","id":"PMC_17613539","title":"Association of attentional network function with exon 5 variations of the CHRNA4 gene.","date":"2007","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17613539","citation_count":59,"is_preprint":false},{"pmid":"19803686","id":"PMC_19803686","title":"The association between dopamine DRD2 polymorphisms and working memory capacity is modulated by a functional polymorphism on the nicotinic receptor gene CHRNA4.","date":"2010","source":"Journal of cognitive neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19803686","citation_count":56,"is_preprint":false},{"pmid":"19020039","id":"PMC_19020039","title":"Rats harboring S284L Chrna4 mutation show attenuation of synaptic and extrasynaptic GABAergic transmission and exhibit the nocturnal frontal lobe epilepsy phenotype.","date":"2008","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19020039","citation_count":53,"is_preprint":false},{"pmid":"18534558","id":"PMC_18534558","title":"Gene-gene interactions among CHRNA4, CHRNB2, BDNF, and NTRK2 in nicotine dependence.","date":"2008","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/18534558","citation_count":52,"is_preprint":false},{"pmid":"22722381","id":"PMC_22722381","title":"The role of the CHRNA4 gene in Internet addiction: a case-control study.","date":"2012","source":"Journal of addiction medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22722381","citation_count":48,"is_preprint":false},{"pmid":"12887446","id":"PMC_12887446","title":"Evidence for S284L mutation of the CHRNA4 in a white family with autosomal dominant nocturnal frontal lobe epilepsy.","date":"2003","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/12887446","citation_count":45,"is_preprint":false},{"pmid":"8833159","id":"PMC_8833159","title":"Exon-intron structure of the human neuronal nicotinic acetylcholine receptor alpha 4 subunit (CHRNA4).","date":"1996","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8833159","citation_count":40,"is_preprint":false},{"pmid":"15727510","id":"PMC_15727510","title":"Modulation of nicotine but not ethanol preference by the mouse Chrna4 A529T polymorphism.","date":"2005","source":"Behavioral neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15727510","citation_count":39,"is_preprint":false},{"pmid":"15026168","id":"PMC_15026168","title":"Candidate gene association studies of the alpha 4 (CHRNA4) and beta 2 (CHRNB2) neuronal nicotinic acetylcholine receptor subunit genes in Alzheimer's disease.","date":"2004","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/15026168","citation_count":38,"is_preprint":false},{"pmid":"15902904","id":"PMC_15902904","title":"Association of polymorphisms in nicotinic acetylcholine receptor alpha 4 subunit gene (CHRNA4), mu-opioid receptor gene (OPRM1), and ethanol-metabolizing enzyme genes with alcoholism in Korean patients.","date":"2004","source":"Alcohol (Fayetteville, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/15902904","citation_count":37,"is_preprint":false},{"pmid":"17590520","id":"PMC_17590520","title":"Nicotine receptor gene CHRNA4 modulates early event-related potentials in auditory and visual oddball target detection tasks.","date":"2007","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/17590520","citation_count":37,"is_preprint":false},{"pmid":"12766617","id":"PMC_12766617","title":"A polymorphism in the alpha4 nicotinic receptor gene (Chrna4) modulates enhancement of nicotinic receptor function by ethanol.","date":"2003","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/12766617","citation_count":36,"is_preprint":false},{"pmid":"19058950","id":"PMC_19058950","title":"A novel mutation of the nicotinic acetylcholine receptor gene CHRNA4 in sporadic nocturnal frontal lobe epilepsy.","date":"2008","source":"Epilepsy research","url":"https://pubmed.ncbi.nlm.nih.gov/19058950","citation_count":35,"is_preprint":false},{"pmid":"9129724","id":"PMC_9129724","title":"Neuronal nicotinic acetylcholine receptor alpha 4 subunit (CHRNA4) and panic disorder: an association study.","date":"1997","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9129724","citation_count":34,"is_preprint":false},{"pmid":"22373960","id":"PMC_22373960","title":"A cognitive phenotype for a polymorphism in the nicotinic receptor gene CHRNA4.","date":"2012","source":"Neuroscience and biobehavioral reviews","url":"https://pubmed.ncbi.nlm.nih.gov/22373960","citation_count":32,"is_preprint":false},{"pmid":"16332175","id":"PMC_16332175","title":"Polymorphisms of the CHRNA4 gene encoding the alpha4 subunit of nicotinic acetylcholine receptor as related to the oxidative DNA damage and the level of apoptotic proteins in lymphocytes of the patients with Alzheimer's disease.","date":"2005","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16332175","citation_count":30,"is_preprint":false},{"pmid":"9216991","id":"PMC_9216991","title":"A nonsense mutation in the alpha4 subunit of the nicotinic acetylcholine receptor (CHRNA4) cosegregates with 20q-linked benign neonatal familial convulsions (EBNI).","date":"1994","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/9216991","citation_count":29,"is_preprint":false},{"pmid":"21500914","id":"PMC_21500914","title":"The nicotinic acetylcholine receptor gene CHRNA4 is associated with negative emotionality.","date":"2011","source":"Emotion (Washington, D.C.)","url":"https://pubmed.ncbi.nlm.nih.gov/21500914","citation_count":28,"is_preprint":false},{"pmid":"26952864","id":"PMC_26952864","title":"A rare missense mutation in CHRNA4 associates with smoking behavior and its consequences.","date":"2016","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/26952864","citation_count":27,"is_preprint":false},{"pmid":"19822871","id":"PMC_19822871","title":"Deletions involving both KCNQ2 and CHRNA4 present with benign familial neonatal seizures.","date":"2009","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/19822871","citation_count":27,"is_preprint":false},{"pmid":"32097883","id":"PMC_32097883","title":"Remarkable effect of transdermal nicotine in children with CHRNA4-related autosomal dominant sleep-related hypermotor epilepsy.","date":"2020","source":"Epilepsy & behavior : E&B","url":"https://pubmed.ncbi.nlm.nih.gov/32097883","citation_count":27,"is_preprint":false},{"pmid":"22008229","id":"PMC_22008229","title":"Association of CHRNA4 polymorphism with depression and loneliness in elderly males.","date":"2011","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/22008229","citation_count":25,"is_preprint":false},{"pmid":"29454195","id":"PMC_29454195","title":"CHRNA4 variant causes paroxysmal kinesigenic dyskinesia and genetic epilepsy with febrile seizures plus?","date":"2018","source":"Seizure","url":"https://pubmed.ncbi.nlm.nih.gov/29454195","citation_count":25,"is_preprint":false},{"pmid":"17504247","id":"PMC_17504247","title":"Association study of the nicotinic acetylcholine receptor alpha4 subunit gene, CHRNA4, in attention-deficit hyperactivity disorder.","date":"2007","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/17504247","citation_count":25,"is_preprint":false},{"pmid":"21445957","id":"PMC_21445957","title":"Association of CHRNA4 polymorphisms with smoking behavior in two populations.","date":"2011","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21445957","citation_count":23,"is_preprint":false},{"pmid":"23350800","id":"PMC_23350800","title":"Nominal association with CHRNA4 variants and nicotine dependence.","date":"2013","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/23350800","citation_count":23,"is_preprint":false},{"pmid":"12871652","id":"PMC_12871652","title":"The mouse Chrna4 A529T polymorphism alters the ratio of high to low affinity alpha 4 beta 2 nAChRs.","date":"2003","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12871652","citation_count":23,"is_preprint":false},{"pmid":"21203548","id":"PMC_21203548","title":"Nicotinic receptor gene CHRNA4 interacts with processing load in attention.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21203548","citation_count":21,"is_preprint":false},{"pmid":"10450598","id":"PMC_10450598","title":"SER252PHE and 776INS3 mutations in the CHRNA4 gene are rare in the Italian ADNFLE population.","date":"1999","source":"Sleep","url":"https://pubmed.ncbi.nlm.nih.gov/10450598","citation_count":21,"is_preprint":false},{"pmid":"38056431","id":"PMC_38056431","title":"Hepatocyte CHRNA4 mediates the MASH-promotive effects of immune cell-produced acetylcholine and smoking exposure in mice and humans.","date":"2023","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/38056431","citation_count":20,"is_preprint":false},{"pmid":"17851150","id":"PMC_17851150","title":"Ring chromosome 20 syndrome without deletions of the subtelomeric and CHRNA4--KCNQ2 genes loci.","date":"2007","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17851150","citation_count":20,"is_preprint":false},{"pmid":"22947540","id":"PMC_22947540","title":"The dopamine D2 receptor gene DRD2 and the nicotinic acetylcholine receptor gene CHRNA4 interact on striatal gray matter volume: evidence from a genetic imaging study.","date":"2012","source":"NeuroImage","url":"https://pubmed.ncbi.nlm.nih.gov/22947540","citation_count":20,"is_preprint":false},{"pmid":"29240768","id":"PMC_29240768","title":"The association between the nicotinic acetylcholine receptor α4 subunit gene (CHRNA4) rs1044396 and Internet gaming disorder in Korean male adults.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29240768","citation_count":19,"is_preprint":false},{"pmid":"20061993","id":"PMC_20061993","title":"Chrna4 A529 knock-in mice exhibit altered nicotine sensitivity.","date":"2010","source":"Pharmacogenetics and genomics","url":"https://pubmed.ncbi.nlm.nih.gov/20061993","citation_count":19,"is_preprint":false},{"pmid":"19693267","id":"PMC_19693267","title":"Financial and psychological risk attitudes associated with two single nucleotide polymorphisms in the nicotine receptor (CHRNA4) gene.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19693267","citation_count":18,"is_preprint":false},{"pmid":"21432576","id":"PMC_21432576","title":"Polymorphisms in the neural nicotinic acetylcholine receptor α4 subunit (CHRNA4) are associated with ADHD in a genetic isolate.","date":"2009","source":"Attention deficit and hyperactivity disorders","url":"https://pubmed.ncbi.nlm.nih.gov/21432576","citation_count":18,"is_preprint":false},{"pmid":"24385388","id":"PMC_24385388","title":"Rare human nicotinic acetylcholine receptor α4 subunit (CHRNA4) variants affect expression and function of high-affinity nicotinic acetylcholine receptors.","date":"2014","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/24385388","citation_count":17,"is_preprint":false},{"pmid":"19577488","id":"PMC_19577488","title":"The 1674+11C>T polymorphism of CHRNA4 is associated with juvenile myoclonic epilepsy.","date":"2009","source":"Seizure","url":"https://pubmed.ncbi.nlm.nih.gov/19577488","citation_count":17,"is_preprint":false},{"pmid":"26079805","id":"PMC_26079805","title":"Nicotinergic Modulation of Attention-Related Neural Activity Differentiates Polymorphisms of DRD2 and CHRNA4 Receptor Genes.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26079805","citation_count":16,"is_preprint":false},{"pmid":"24428733","id":"PMC_24428733","title":"Association of the CHRNA4 neuronal nicotinic receptor subunit gene with frequency of binge drinking in young adults.","date":"2014","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/24428733","citation_count":15,"is_preprint":false},{"pmid":"28877969","id":"PMC_28877969","title":"Overdominant Effect of a CHRNA4 Polymorphism on Cingulo-Opercular Network Activity and Cognitive Control.","date":"2017","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28877969","citation_count":15,"is_preprint":false},{"pmid":"37495067","id":"PMC_37495067","title":"Decreased expression of Chrna4 by METTL3-mediated m6A modification participates in BPA-induced spatial memory deficit.","date":"2023","source":"Environmental research","url":"https://pubmed.ncbi.nlm.nih.gov/37495067","citation_count":13,"is_preprint":false},{"pmid":"21753767","id":"PMC_21753767","title":"Autosomal dominant nocturnal frontal lobe epilepsy: a genotypic comparative study of Japanese and Korean families carrying the CHRNA4 Ser284Leu mutation.","date":"2011","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21753767","citation_count":13,"is_preprint":false},{"pmid":"11121188","id":"PMC_11121188","title":"Failure to replicate association between the gene for the neuronal nicotinic acetylcholine receptor alpha 4 subunit (CHRNA4) and IGE.","date":"2000","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11121188","citation_count":13,"is_preprint":false},{"pmid":"24498031","id":"PMC_24498031","title":"Massive withdrawal symptoms and affective vulnerability are associated with variants of the CHRNA4 gene in a subgroup of smokers.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24498031","citation_count":12,"is_preprint":false},{"pmid":"1492743","id":"PMC_1492743","title":"The genes coding for phosphoenolpyruvate carboxykinase-1 (PCK1) and neuronal nicotinic acetylcholine receptor alpha 4 subunit (CHRNA4) map to human chromosome 20, extending the known region of homology with mouse chromosome 2.","date":"1992","source":"Annals of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/1492743","citation_count":12,"is_preprint":false},{"pmid":"27611310","id":"PMC_27611310","title":"CHRNA4 and ANKK1 Polymorphisms Influence Smoking-Induced Nicotinic Acetylcholine Receptor Upregulation.","date":"2016","source":"Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco","url":"https://pubmed.ncbi.nlm.nih.gov/27611310","citation_count":11,"is_preprint":false},{"pmid":"32536355","id":"PMC_32536355","title":"Variants in CHRNB2 and CHRNA4 Identified in Patients with Insular Epilepsy.","date":"2020","source":"The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques","url":"https://pubmed.ncbi.nlm.nih.gov/32536355","citation_count":11,"is_preprint":false},{"pmid":"25647695","id":"PMC_25647695","title":"Modulation of nicotine effects on selective attention by DRD2 and CHRNA4 gene polymorphisms.","date":"2015","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25647695","citation_count":11,"is_preprint":false},{"pmid":"23240931","id":"PMC_23240931","title":"A novel differential susceptibility gene: CHRNA4 and moderation of the effect of maltreatment on child personality.","date":"2012","source":"Journal of child psychology and psychiatry, and allied disciplines","url":"https://pubmed.ncbi.nlm.nih.gov/23240931","citation_count":11,"is_preprint":false},{"pmid":"23037950","id":"PMC_23037950","title":"Possible association of nicotinic acetylcholine receptor gene (CHRNA4 and CHRNB2) polymorphisms with nicotine dependence in Japanese males: an exploratory study.","date":"2012","source":"Pharmacopsychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/23037950","citation_count":11,"is_preprint":false},{"pmid":"17488453","id":"PMC_17488453","title":"Effects of APOE and CHRNA4 genotypes on retinal nerve fibre layer thickness at the optic disc and on risk for developing exfoliation syndrome.","date":"2007","source":"Acta ophthalmologica Scandinavica","url":"https://pubmed.ncbi.nlm.nih.gov/17488453","citation_count":11,"is_preprint":false},{"pmid":"25639542","id":"PMC_25639542","title":"Individual response speed is modulated by variants of the gene encoding the alpha 4 sub-unit of the nicotinic acetylcholine receptor (CHRNA4).","date":"2015","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/25639542","citation_count":11,"is_preprint":false},{"pmid":"7607646","id":"PMC_7607646","title":"Detection of a CfoI polymorphism within exon 5 of the human neuronal nicotinic acetylcholine receptor alpha 4 subunit gene (CHRNA4).","date":"1995","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/7607646","citation_count":11,"is_preprint":false},{"pmid":"20331911","id":"PMC_20331911","title":"Epistasis between APOE and nicotinic receptor gene CHRNA4 in age related cognitive function and decline.","date":"2010","source":"Journal of the International Neuropsychological Society : JINS","url":"https://pubmed.ncbi.nlm.nih.gov/20331911","citation_count":10,"is_preprint":false},{"pmid":"18762859","id":"PMC_18762859","title":"Genetic association analysis of tagging SNPs in alpha4 and beta2 subunits of neuronal nicotinic acetylcholine receptor genes (CHRNA4 and CHRNB2) with schizophrenia in the Japanese population.","date":"2008","source":"Journal of neural transmission (Vienna, Austria : 1996)","url":"https://pubmed.ncbi.nlm.nih.gov/18762859","citation_count":10,"is_preprint":false},{"pmid":"25282705","id":"PMC_25282705","title":"A novel mutation of the nicotinic acetylcholine receptor gene CHRNA4 in a Chinese patient with non-familial nocturnal frontal lobe epilepsy.","date":"2014","source":"Epilepsy research","url":"https://pubmed.ncbi.nlm.nih.gov/25282705","citation_count":9,"is_preprint":false},{"pmid":"28582665","id":"PMC_28582665","title":"The influence of CHRNA4, COMT, and maternal sensitivity on orienting and executive attention in 6-month-old infants.","date":"2017","source":"Brain and cognition","url":"https://pubmed.ncbi.nlm.nih.gov/28582665","citation_count":9,"is_preprint":false},{"pmid":"26309560","id":"PMC_26309560","title":"Mutational analysis of CHRNB2, CHRNA2 and CHRNA4 genes in Chinese population with autosomal dominant nocturnal frontal lobe epilepsy.","date":"2015","source":"International journal of clinical and experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26309560","citation_count":9,"is_preprint":false},{"pmid":"25667822","id":"PMC_25667822","title":"Contiguous deletion of KCNQ2 and CHRNA4 may cause a different disorder from benign familial neonatal seizures.","date":"2013","source":"Epilepsy & behavior case reports","url":"https://pubmed.ncbi.nlm.nih.gov/25667822","citation_count":8,"is_preprint":false},{"pmid":"10549797","id":"PMC_10549797","title":"Mutation screening of the CHRNA4 and CHRNB2 nicotinic cholinergic receptor genes in Alzheimer's disease.","date":"1999","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/10549797","citation_count":8,"is_preprint":false},{"pmid":"22873564","id":"PMC_22873564","title":"Replication of association of CHRNA4 rare variants with sporadic amyotrophic lateral sclerosis: the Italian multicentre study.","date":"2012","source":"Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases","url":"https://pubmed.ncbi.nlm.nih.gov/22873564","citation_count":8,"is_preprint":false},{"pmid":"26125703","id":"PMC_26125703","title":"Association of CHRNA4 gene rs1044396 and rs1044397 polymorphisms with Parkinson's disease symptoms and smoking.","date":"2015","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/26125703","citation_count":7,"is_preprint":false},{"pmid":"27109789","id":"PMC_27109789","title":"Cholinergic modulation of auditory P3 event-related potentials as indexed by CHRNA4 and CHRNA7 genotype variation in healthy volunteers.","date":"2016","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/27109789","citation_count":7,"is_preprint":false},{"pmid":"29630124","id":"PMC_29630124","title":"Study of candidate gene cHRNA4 for familial epilepsy syndrome.","date":"2018","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29630124","citation_count":6,"is_preprint":false},{"pmid":"31821848","id":"PMC_31821848","title":"Depletion of miR-380 mitigates human bronchial epithelial cells injury to improve chronic obstructive pulmonary disease through targeting CHRNA4.","date":"2019","source":"Molecular and cellular probes","url":"https://pubmed.ncbi.nlm.nih.gov/31821848","citation_count":6,"is_preprint":false},{"pmid":"32031532","id":"PMC_32031532","title":"Two mutations in the nicotinic acetylcholine receptor subunit A4 (CHRNA4) in a family with autosomal dominant sleep-related hypermotor epilepsy.","date":"2020","source":"Epileptic disorders : international epilepsy journal with videotape","url":"https://pubmed.ncbi.nlm.nih.gov/32031532","citation_count":5,"is_preprint":false},{"pmid":"39193833","id":"PMC_39193833","title":"Clinical, molecular, physiologic, and therapeutic feature of patients with CHRNA4 and CHRNB2 deficiency: A systematic review.","date":"2024","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/39193833","citation_count":3,"is_preprint":false},{"pmid":"23720086","id":"PMC_23720086","title":"Polymorphism in the CHRNA4 gene is associated with rapid scene categorization performance.","date":"2013","source":"Attention, perception & psychophysics","url":"https://pubmed.ncbi.nlm.nih.gov/23720086","citation_count":3,"is_preprint":false},{"pmid":"11090267","id":"PMC_11090267","title":"A new biallelic polymorphism in intron 1 of the CHRNA4 gene may cause erroneous genotyping of a closely linked CA repeat marker.","date":"2000","source":"Molecular and cellular probes","url":"https://pubmed.ncbi.nlm.nih.gov/11090267","citation_count":2,"is_preprint":false},{"pmid":"39647824","id":"PMC_39647824","title":"Prenatal Hypoxia Predisposes to Impaired Expression of the chrna4 and chrna7 Genes in Adult Rats without Affecting Acetylcholine Metabolism during Embryonic Development.","date":"2024","source":"Biochemistry. Biokhimiia","url":"https://pubmed.ncbi.nlm.nih.gov/39647824","citation_count":1,"is_preprint":false},{"pmid":"24327142","id":"PMC_24327142","title":"[Clinical features and mutation analysis of CHRNA4 gene for families and sporadic cases affected with autosomal dominant nocturnal frontal lobe epilepsy].","date":"2013","source":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24327142","citation_count":1,"is_preprint":false},{"pmid":"26612384","id":"PMC_26612384","title":"Replication of the association between CHRNA4 rs1044396 and harm avoidance in a large population-based sample.","date":"2015","source":"European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/26612384","citation_count":1,"is_preprint":false},{"pmid":"31813155","id":"PMC_31813155","title":"[Association of CHRNA4 gene polymorphisms with response to antidepressant among ethnic Han Chinese].","date":"2019","source":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31813155","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.10.13.618070","title":"From Transcriptomic Signatures to Active-Site Docking and ADMET Properties Prediction: Bioinformatics-Guided Exploration of Binding Mechanisms of Cardioprotective Phytoconstituents Against Dysregulated Targets in Hypertrophic Cardiomyopathy","date":"2024-10-15","source":"bioRxiv","url":"https://doi.org/10.1101/2024.10.13.618070","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":39849,"output_tokens":2691,"usd":0.079956,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10070,"output_tokens":3336,"usd":0.066875,"stage2_stop_reason":"end_turn"},"total_usd":0.146831,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"An insertion of three nucleotides (GCT) at position 776 in the M2 domain of CHRNA4 does not prevent receptor function but increases apparent affinity for ACh and significantly lowers calcium permeability of the reconstituted receptor, corresponding to a loss-of-function at the cellular level.\",\n      \"method\": \"Receptor reconstitution and electrophysiological characterization in heterologous expression system\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with functional electrophysiology, single lab but two distinct functional parameters measured (ACh affinity and calcium permeability)\",\n      \"pmids\": [\"9175743\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"A C755T missense mutation in exon 5 of CHRNA4 replaces Ser252 (a conserved residue in the M2 channel-lining domain) with leucine, causing ADNFLE; the serine at this position is considered important for channel function.\",\n      \"method\": \"SSCP, direct sequencing, segregation analysis\",\n      \"journal\": \"Neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — genetic/sequencing identification with segregation, no direct functional reconstitution in this paper; replicated across multiple ADNFLE families\",\n      \"pmids\": [\"10563623\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"A novel CHRNA4 mutation (T265I) at the extracellular end of the second transmembrane domain increases ACh sensitivity of mutated α4β2 receptors as demonstrated by expression in Xenopus oocytes.\",\n      \"method\": \"Expression in Xenopus oocytes, electrophysiological characterization\",\n      \"journal\": \"Epilepsia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct functional reconstitution in Xenopus oocyte system with electrophysiology, single lab\",\n      \"pmids\": [\"12823585\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The Chrna4 A529T polymorphism in the second intracellular loop of the α4 subunit alters the ratio of high- to low-affinity α4β2 nAChR populations: the T529 variant exhibits a higher EC50 for the high-affinity population and a greater proportion of high-affinity receptors (64%) compared with A529 (41%), and shows reduced sensitivity to DHβE blockade.\",\n      \"method\": \"Heterologous expression of mouse α4 variants with β2 subunit, electrophysiology\",\n      \"journal\": \"Neuropharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with functional electrophysiology comparing two variant forms, single lab with multiple functional endpoints\",\n      \"pmids\": [\"12871652\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The Chrna4 A529 polymorphism (versus T529) in mouse strains enables ethanol (10–100 mM) to enhance maximal nicotine-stimulated 86Rb+ efflux from thalamic synaptosomes; one copy of the A allele is sufficient for this enhancement, and the effect requires the β2 subunit.\",\n      \"method\": \"86Rb+ efflux assay in thalamic synaptosomes from inbred mouse strains and F2 hybrids\",\n      \"journal\": \"Alcoholism, clinical and experimental research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro functional assay replicated across six inbred strains and F2 intercross, multiple genetic backgrounds tested\",\n      \"pmids\": [\"12766617\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Transgenic rats expressing the CHRNA4 S284L mutation show attenuation of synaptic and extrasynaptic GABAergic transmission and abnormal glutamate release during slow-wave sleep, establishing that this gain-of-function mutation disrupts inhibitory neurotransmission as a mechanism for NFLE seizures.\",\n      \"method\": \"Transgenic rat model (knock-in S284L), electrophysiological recordings of synaptic transmission, behavioral seizure phenotyping\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean transgenic knock-in animal model with defined cellular electrophysiology phenotype (GABAergic and glutamatergic transmission), multiple readouts\",\n      \"pmids\": [\"19020039\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Chrna4 A529 knock-in mice exhibit greater sensitivity to nicotine-induced hypothermia, reduced oral nicotine consumption, no conditioned place preference to nicotine, and altered α4β2* nAChR function in midbrain (greater maximal Rb+ efflux and higher proportion of high-sensitivity receptors), demonstrating that the T529A polymorphism causally influences nicotine sensitivity through midbrain α4β2* nAChRs.\",\n      \"method\": \"Knock-in mouse model, behavioral pharmacology, acetylcholine-stimulated Rb+ efflux in midbrain\",\n      \"journal\": \"Pharmacogenetics and genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — knock-in model with multiple orthogonal behavioral and biochemical endpoints, definitively assigns causal role to polymorphism\",\n      \"pmids\": [\"20061993\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Three rare CHRNA4 variants (α4R336C, α4P451L, α4R487Q) alter α4β2 nAChR expression, subcellular distribution, sensitivity to nicotine-induced receptor upregulation, intracellular interactome composition (by LC-MS/MS), and electrophysiological parameters of agonist activation in Xenopus oocytes, indicating that single amino acid substitutions in CHRNA4 affect receptor assembly and pharmacology.\",\n      \"method\": \"[3H]epibatidine binding, LC-MS/MS proteomics of immunopurified receptors, voltage-clamp electrophysiology in Xenopus oocytes, subcellular fractionation in HEK293 cells\",\n      \"journal\": \"The Journal of pharmacology and experimental therapeutics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple orthogonal methods (binding, proteomics, electrophysiology, fractionation) in a single study characterizing three variants\",\n      \"pmids\": [\"24385388\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Hepatocyte-expressed CHRNA4 mediates MASH progression by acting as an ionotropic receptor: acetylcholine (from immune cells) or nicotine activates hepatocyte CHRNA4, inducing calcium influx and activation of inflammatory signaling, leading to cytokine production and liver inflammation. Genetic and pharmacological inhibition of CHRNA4 protected mice from diet-induced MASH.\",\n      \"method\": \"Conditional knockout mice, pharmacological inhibition, calcium imaging, inflammatory cytokine measurements, dietary MASH model\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic (KO) and pharmacological loss-of-function with defined cellular mechanism (calcium influx, inflammatory signaling) and disease phenotype rescue\",\n      \"pmids\": [\"38056431\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"METTL3-mediated m6A modification is enriched on Chrna4 mRNA in hippocampal neurons following BPA exposure, leading to decreased Chrna4 expression; inhibition or knockdown of METTL3 restores Chrna4 expression and rescues BPA-induced spatial memory deficits and abnormal synaptic transmission.\",\n      \"method\": \"m6A sequencing/MeRIP, METTL3 inhibitor and shRNA knockdown in neurons and rats, synaptic transmission recordings, behavioral memory testing\",\n      \"journal\": \"Environmental research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple methods (m6A profiling, genetic KD, pharmacological inhibition, behavioral rescue) in single lab; m6A site on Chrna4 mRNA identified but direct reader/eraser not fully characterized\",\n      \"pmids\": [\"37495067\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"The human CHRNA4 gene consists of six exons distributed over approximately 17 kb of genomic DNA, providing the structural basis for mutation screening of the complete coding region.\",\n      \"method\": \"Genomic sequencing, Southern blot analysis, PCR amplification\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct genomic characterization establishing gene structure; foundational for all subsequent mutation studies\",\n      \"pmids\": [\"8833159\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CHRNA4 encodes the α4 subunit of the neuronal nicotinic acetylcholine receptor (nAChR); it assembles with the β2 subunit to form high-affinity α4β2 ion channels that conduct calcium and are gated by acetylcholine/nicotine, with disease-causing mutations in the M2 channel-lining domain increasing ACh sensitivity or reducing calcium permeability, a polymorphism in the second intracellular loop (A/T529) controlling the ratio of high- to low-affinity receptor populations and their ethanol modulation, rare coding variants altering receptor assembly/expression/pharmacology, METTL3-mediated m6A modification on CHRNA4 mRNA suppressing its expression and impairing synaptic transmission, and hepatocyte CHRNA4 specifically mediating acetylcholine/nicotine-induced calcium influx and inflammatory signaling to drive metabolic liver disease.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CHRNA4 encodes the α4 subunit of a neuronal nicotinic acetylcholine receptor that assembles with the β2 subunit to form an acetylcholine/nicotine-gated, calcium-conducting ion channel [#4, #6]. The M2 channel-lining domain is the critical functional determinant: mutations there alter receptor behavior, with an M2 GCT insertion increasing apparent ACh affinity while reducing calcium permeability [#0], and the S252L and T265I substitutions in the same region increasing ACh sensitivity and causing autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE/NFLE) [#1, #2]. The gain-of-function S284L mutation expressed in transgenic rats attenuates GABAergic transmission and produces abnormal glutamate release during slow-wave sleep, establishing disrupted inhibitory neurotransmission as the seizure mechanism [#5]. A polymorphism in the second intracellular loop (A529/T529) shifts the ratio of high- to low-affinity α4β2 receptor populations and their pharmacology in a β2-dependent manner [#3], and in knock-in mice this variant causally modulates nicotine sensitivity, consumption, and reward through midbrain α4β2* receptors and gates ethanol enhancement of nicotine-stimulated cation efflux [#4, #6]. Rare coding variants (R336C, P451L, R487Q) further perturb receptor expression, subcellular distribution, nicotine-induced upregulation, intracellular interactome, and agonist pharmacology [#7]. Beyond the nervous system, hepatocyte CHRNA4 acts as an ionotropic receptor whose activation by immune-cell-derived acetylcholine or nicotine drives calcium influx and inflammatory signaling to promote metabolic dysfunction-associated steatohepatitis (MASH) [#8]. CHRNA4 expression is also subject to METTL3-mediated m6A modification of its mRNA, which suppresses its expression and impairs synaptic transmission [#9].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Defining the genomic organization of CHRNA4 was the prerequisite for systematic mutation screening, answering how the coding region is structured.\",\n      \"evidence\": \"genomic sequencing, Southern blot, and PCR mapping of the human gene\",\n      \"pmids\": [\"8833159\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Provides no functional or regulatory information\", \"Does not address protein assembly or channel properties\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Reconstitution of an M2-domain insertion mutant established that CHRNA4 mutations can dissociate gating from permeation, increasing ACh affinity while lowering calcium permeability.\",\n      \"evidence\": \"receptor reconstitution and electrophysiology in a heterologous expression system\",\n      \"pmids\": [\"9175743\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Single lab, single mutant\", \"Does not establish in vivo or disease consequence\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Genetic identification of the S252L M2 mutation linked CHRNA4 channel-lining residues to ADNFLE, implicating M2 integrity in disease.\",\n      \"evidence\": \"SSCP, direct sequencing, and segregation analysis in ADNFLE families\",\n      \"pmids\": [\"10563623\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No direct functional reconstitution in this study\", \"Mechanism connecting mutation to seizures not resolved here\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Functional reconstitution of the T265I mutation showed that disease-associated M2 substitutions confer increased ACh sensitivity, defining a gain-of-function pharmacology.\",\n      \"evidence\": \"expression of mutant α4β2 in Xenopus oocytes with electrophysiology\",\n      \"pmids\": [\"12823585\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Single lab\", \"Link from altered sensitivity to circuit dysfunction not tested\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Characterization of the A529T intracellular-loop polymorphism established that non-M2 variants tune the proportion and affinity of receptor populations and their antagonist sensitivity.\",\n      \"evidence\": \"heterologous expression of α4 variants with β2 and electrophysiology; 86Rb+ efflux in mouse thalamic synaptosomes showing β2-dependent ethanol enhancement\",\n      \"pmids\": [\"12871652\", \"12766617\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vitro and synaptosomal assays only\", \"Behavioral relevance not yet established at this stage\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"A transgenic S284L rat connected a CHRNA4 gain-of-function mutation to attenuated GABAergic transmission and abnormal glutamate release during slow-wave sleep, providing a circuit-level mechanism for NFLE seizures.\",\n      \"evidence\": \"knock-in transgenic rat with synaptic electrophysiology and seizure phenotyping\",\n      \"pmids\": [\"19020039\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Single mutation model\", \"Does not address how altered channel kinetics map to network changes\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"A529 knock-in mice assigned a causal role for the polymorphism in nicotine sensitivity, consumption, and reward via midbrain α4β2* receptors.\",\n      \"evidence\": \"knock-in mouse, behavioral pharmacology, and ACh-stimulated Rb+ efflux in midbrain\",\n      \"pmids\": [\"20061993\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mouse variant; human translation not directly tested\", \"Circuit specificity beyond midbrain not resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Multi-modal characterization of three rare coding variants showed that single substitutions reshape receptor expression, trafficking, upregulation, intracellular interactome, and pharmacology.\",\n      \"evidence\": \"epibatidine binding, LC-MS/MS of immunopurified receptors, oocyte electrophysiology, HEK293 subcellular fractionation\",\n      \"pmids\": [\"24385388\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interactome partners not individually validated\", \"In vivo phenotype of these variants not tested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Hepatocyte CHRNA4 was established as an ionotropic driver of liver disease, where acetylcholine/nicotine triggers calcium influx and inflammatory signaling to promote MASH.\",\n      \"evidence\": \"conditional knockout and pharmacological inhibition in a dietary MASH model with calcium imaging and cytokine measurement\",\n      \"pmids\": [\"38056431\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Subunit composition of the hepatic receptor not defined\", \"Downstream inflammatory signaling steps only partially mapped\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"m6A profiling identified CHRNA4 mRNA as a METTL3 target whose methylation suppresses expression and impairs synaptic transmission after BPA exposure.\",\n      \"evidence\": \"MeRIP/m6A sequencing, METTL3 inhibitor and shRNA knockdown, synaptic recordings, and behavioral memory testing in neurons and rats\",\n      \"pmids\": [\"37495067\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"m6A reader/eraser controlling CHRNA4 not identified\", \"Direct causality from a specific methylation site not fully resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The subunit composition and structural basis of non-neuronal (hepatocyte) CHRNA4 receptors and how the same channel mediates both seizure-related neurotransmission and peripheral inflammatory signaling remain unresolved.\",\n      \"evidence\": null,\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of mutant or hepatic receptors in the corpus\", \"Tissue-specific assembly partners beyond β2 not defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 2, 3, 4, 6, 8]},\n      {\"term_id\": \"GO:0005216\", \"supporting_discovery_ids\": [0, 8]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 2, 4, 6, 8]},\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [7, 8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [5, 6, 9]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [8]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [1, 5, 8]}\n    ],\n    \"complexes\": [\"α4β2 nicotinic acetylcholine receptor\"],\n    \"partners\": [\"CHRNB2\", \"METTL3\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}